Table 1.
Baseline Participant Characteristics
| Characteristics | Varenicline + bupropion | Varenicline + placebo |
|---|---|---|
| n = 84 | n = 90 | |
| Age, mean (SD) | 43.1 (10.6) | 44.8 (11.4) |
| Men, n (%) | 84 (100) | 90 (100) |
| Race, n (%) | ||
| White | 57 (67.9) | 66 (73.3) |
| Black | 26 (31.0) | 20 (22.2) |
| Other | 1 (1.2) | 4 (4.4) |
| Number of years smoked, mean (SD) | 23.1 (10.6) | 24.4 (11.1) |
| Number of cigarettes/d, mean (SD) | 20.2 (7.7) | 19.8 (7.1) |
| FTND score, mean (SD) | 5.6 (1.8) | 5.4 (1.9) |
| Number of prior attempts to quit, mean (SD) | 8.6 (15.4) | 9.8 (18.2) |
| Expired-air CO (ppm), mean (SD) | 28.2 (12.0) | 27.3 (10.8) |
| Number of participants (%) having CO > 30 ppm (42-mg patch dose wk 1) | 29 (34.5) | 30 (33.3) |
FTND = Fagerstrom Test for Nicotine Dependence.